Adaptin Bio is a pioneering biotechnology business focused to transforming medicine delivery.
Adaptin Bio has raised $1.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Adaptin Bio is headquartered in Charlotte, United States.
Adaptin Bio is a pioneering biotechnology business focused to transforming medicine delivery.
Adaptin Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adaptin Bio — Funding & Investors." VCBacked, December 24, 2025, https://www.vcbacked.co/company/adaptin-bio. Accessed August 16, 2026.
VCBacked. (2025). Adaptin Bio — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/adaptin-bio
{{cite web |title=Adaptin Bio — Funding & Investors |url=https://www.vcbacked.co/company/adaptin-bio |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated